title: Asenapine-Induced Acute Dystonia in an Adolescent Male.
abstract: Asenapine is a sublingually absorbed newer second-generation antipsychotic that is approved for the treatment of schizophrenia and bipolar disorder in patients, with a lower extrapyramidal adverse effect potential. We report an adolescent boy having schizophrenia who developed an acute dystonic reaction after 4 days when the dose of asenapine was increased from 10 to 15 mg per day.
authors.affiliation: 1 Department of Psychiatry, Assam Medical College , Dibrugarh, India .
authors.forename: Dhrubajyoti
authors.initials: D
authors.lastname: Bhuyan
authors.affiliation: 1 Department of Psychiatry, Assam Medical College , Dibrugarh, India .
authors.forename: Soumitra
authors.initials: S
authors.lastname: Ghosh
authors.affiliation: 2 Tata Motors Hospital , Jamshedpur, India .
authors.forename: Arnab
authors.initials: A
authors.lastname: Bhattacharya
authors.affiliation: 3 Department of Psychiatry, Kasturba Medical College , Manipal, India .
authors.forename: Samir Kumar
authors.initials: SK
authors.lastname: Praharaj
mesh_terms: D000208:Acute Disease; D000286:Administration, Sublingual; D000293:Adolescent; D014150:Antipsychotic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D003986:Dibenzocycloheptenes; D004305:Dose-Response Relationship, Drug; D004421:Dystonia / Q000139:chemically induced*; D006576:Heterocyclic Compounds, 4 or More Rings / Q000008:administration & dosage / Q000009:adverse effects*; D006801:Humans; D008297:Male; D012559:Schizophrenia / Q000188:drug therapy*
chemical_list: D014150:Antipsychotic Agents; D003986:Dibenzocycloheptenes; D006576:Heterocyclic Compounds, 4 or More Rings; C522667:asenapine